Feature Channels: Cardiovascular Health

Filters close

Not for public release

This news release is embargoed until 10-Jun-2024 5:00 PM EDT Released to reporters: 4-Jun-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 13-Jun-2024 8:00 AM EDT Released to reporters: 10-Jun-2024 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-Jun-2024 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Intervention Aims to Improve Cardiovascular Health for South Asian Populations
Released: 10-Jun-2024 11:05 AM EDT
Intervention Aims to Improve Cardiovascular Health for South Asian Populations
University of Utah Health

People from South Asian countries tend to develop heart disease 10 years earlier than other populations. Kevin Shah, MD, is working to change that.

Newswise: Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)
Released: 10-Jun-2024 7:00 AM EDT
Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)
Mount Sinai Health System

President of Mount Sinai Fuster Heart Hospital given top honor for his scientific excellence and successful global education initiatives on cardiovascular disease

access_time Embargo lifts in 2 days
This news release is embargoed until 11-Jun-2024 5:00 AM EDT Released to reporters: 10-Jun-2024 5:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-Jun-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Jun-2024 4:00 PM EDT Released to reporters: 7-Jun-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jun-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: High Blood Pressure in the Hospital: What Doctors Should Know
Released: 6-Jun-2024 3:05 PM EDT
High Blood Pressure in the Hospital: What Doctors Should Know
University of Utah Health

A new statement from the American Heart Association recommends a much more conservative approach to treating high blood pressure in acute care.

Newswise: UTSW studies clarify link between exercise, risk of heart disease
Released: 6-Jun-2024 11:05 AM EDT
UTSW studies clarify link between exercise, risk of heart disease
UT Southwestern Medical Center

Exercising at a high level doesn’t affect the progression of calcium buildup in the arteries, even among older athletes such as marathoners who tend to have higher coronary artery calcium (CAC) scores, according to new research from UT Southwestern Medical Center. But a longer duration of exercise is associated with higher CAC.

Released: 6-Jun-2024 10:05 AM EDT
Regenerating Damaged Heart Cells
Ann and Robert H. Lurie Children's Hospital of Chicago

Scientists from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago have discovered a way to regenerate damaged heart muscle cells in mice, a development which may provide a new avenue for treating congenital heart defects in children and heart attack damage in adults, according to a study published in the Journal of Clinical Investigation.

Newswise: Cleveland Clinic-Led Study Links Sugar Substitute to Increased Risk of Heart Attack and Stroke
3-Jun-2024 3:05 PM EDT
Cleveland Clinic-Led Study Links Sugar Substitute to Increased Risk of Heart Attack and Stroke
Cleveland Clinic

 Cleveland Clinic researchers found higher amounts of the sugar alcohol xylitol are associated with increased risk of cardiovascular events like heart attack and stroke.

Newswise: Study reveals how 'forever chemicals' may impact heart health in older women
Released: 5-Jun-2024 10:05 AM EDT
Study reveals how 'forever chemicals' may impact heart health in older women
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

New research from the University of Illinois Urbana-Champaign has linked multiple types of per- and polyfluoroalkyl substances (PFAS, also known as “forever chemicals”) with increased risk of cardiovascular diseases in postmenopausal women. Specifically, the study reveals how PFAS chemicals interact with pro-inflammatory pathways in older women, providing potential explanations for the increased risk.

Released: 4-Jun-2024 11:05 AM EDT
Comparative Study on Dual vs Single Cardioversion for Atrial Fibrillation in Obese Patients
Ochsner Health

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial fibrillation and obesity.

Released: 3-Jun-2024 4:05 PM EDT
Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns
University of Chicago Medical Center

Studies from multiple UChicago experts show that while GLP-1RA drugs are extremely effective for weight loss and Type 2 diabetes treatment, there's no one-size-fits-all solution and physicians and patients have to consider issues like cost and side effects.

Released: 3-Jun-2024 7:05 AM EDT
Fewer than 1 in 4 patients receive dietary counseling after a heart attack
Michigan Medicine - University of Michigan

Although diet is the leading contributor to premature death from heart disease in the United States, fewer than one-quarter of people who undergo major heart events receive dietary counseling in the aftermath, a study finds. The reason for such a low rate, researchers suggest, may be a lack of time for providing the counseling or expertise in this area by clinicians.

Released: 3-Jun-2024 4:05 AM EDT
Jejum intermitente aumenta o risco de doença cardíaca?
Mayo Clinic

Há muitos anos, pessoas têm utilizado o jejum intermitente para perder quilos indesejados, enquanto outras jejuam por razões religiosas. A tendência popular da dieta é geralmente segura, mas alguns estudos sugerem que comer com restrição de tempo pode causar problemas cardíacos.

29-May-2024 9:00 AM EDT
Telemedicine may increase endocrinology care access for under-resourced patients with diabetes and heart disease
Endocrine Society

Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Two medication classes reduced cardiovascular and liver events in people with type 2 diabetes
Endocrine Society

GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Hot flashes in menopausal women may signal increased risk for heart and metabolic issues
Endocrine Society

Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom severity, according to research being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Risk for heart attack and stroke increases in people with obesity for a decade or more
Endocrine Society

People under age 50 have a greater risk for heart attack or stroke if they’ve lived with obesity for 10 years, according to industry-sponsored research being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Newswise: Simulation Sessions Help ICU Clinicians Prepare for High-Risk, Infrequent Emergency Procedures
29-May-2024 12:05 PM EDT
Simulation Sessions Help ICU Clinicians Prepare for High-Risk, Infrequent Emergency Procedures
American Association of Critical-Care Nurses (AACN)

The cardiovascular ICU at the University of Mississippi Medical Center developed a simulation training program to improve clinicians’ ability to recognize clinical signs that would prompt an emergency ICU sternotomy for a postoperative cardiac surgery patient and rehearse the high-risk but infrequent procedure.

Newswise: 1920_cedars-sinai-medical-center-3.jpg?10000
Released: 31-May-2024 11:05 AM EDT
May Monthly Research Highlights Newsletter
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: 3D-printed grafts: a breakthrough in combating post-surgical thrombosis and aneurysm
Released: 31-May-2024 9:05 AM EDT
3D-printed grafts: a breakthrough in combating post-surgical thrombosis and aneurysm
Chinese Academy of Sciences

A new study presents the development of 3D printed electrospun vascular grafts infused with tetramethylpyrazine (TMP), offering a potential solution to reduce thrombosis and restrain aneurysmal dilatation post-surgery. This innovation has potential implications for improving cardiovascular disease treatments.

   
Released: 30-May-2024 11:05 AM EDT
Cause of common type of heart failure may differ for women and men
UC Davis Health

A new mouse study of heart failure with preserved ejection fraction (HFpEF) found sex differences at the cellular level. The findings could have implications for how HFpEF is treated in women compared to men.

Released: 29-May-2024 1:05 PM EDT
The Ludmila and Edward Smolyansky Foundation Pledges $1 Million in Support of Lurie Children’s
Ann and Robert H. Lurie Children's Hospital of Chicago

The Ludmila and Edward Smolyansky Foundation, the philanthropic arm Pure Culture Organics of Chicago, IL, announced today it has made a $1 million commitment to Ann & Robert H. Lurie Children’s Hospital of Chicago, specifically allocated to the Cardiology Program Fund and the Access for Every Child Fund.

Newswise: AI Health Coach Lowers Blood Pressure and Boosts Engagement in Patients With Hypertension
Released: 29-May-2024 11:05 AM EDT
AI Health Coach Lowers Blood Pressure and Boosts Engagement in Patients With Hypertension
JMIR Publications

AI Health Coach Lowers Blood Pressure and Boosts Engagement in Patients With Hypertension

   
Newswise: RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial
Released: 29-May-2024 5:30 AM EDT
RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial
Mount Sinai Health System

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

Newswise: Leadless dual-chamber pacemaker a leap forward for heart patients
Released: 28-May-2024 12:05 PM EDT
Leadless dual-chamber pacemaker a leap forward for heart patients
UT Southwestern Medical Center

In 2023, the U.S. Food and Drug Administration in 2023 approved the world’s first leadless dual-chamber pacemaker, a potential gamechanger for the nearly 80% of patients who require pacing of both the upper and lower chambers of the heart. UT Southwestern is one of just nine heart centers in Texas to offer this advanced technology, which implants two capsule-shaped devices smaller than AAA batteries directly inside the heart in a catheter-based procedure, with no large incisions and no lead wires.

Released: 28-May-2024 12:05 PM EDT
Sistema arterial periférico corre el riesgo de desarrollar una enfermedad debido a historia familiar y estilo de vida
Mayo Clinic

La mayoría de la gente ha oído hablar de ataques cardíacos que se producen debido al bloqueo de una arteria coronaria. Sin embargo, el cuerpo tiene dos tipos de sistemas arteriales: el sistema de la arteria coronaria, conectado al corazón, y el sistema arterial periférico, que involucra las arterias que transportan sangre oxigenada a los brazos, piernas, cerebro y el resto del cuerpo.

Not for public release

This news release is embargoed until 27-May-2024 5:00 PM EDT Released to reporters: 21-May-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 27-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Valentin Fuster, MD, PhD, Receives Prestigious Award From World Heart Federation
Released: 23-May-2024 9:30 AM EDT
Valentin Fuster, MD, PhD, Receives Prestigious Award From World Heart Federation
Mount Sinai Health System

President of Mount Sinai Fuster Heart Hospital given top honor for his contributions to combating cardiovascular disease worldwide

Released: 22-May-2024 9:05 AM EDT
New York Valves 2024 Late-Breaking Clinical Trials and Science Announced
Cardiovascular Research Foundation (CRF)

The Cardiovascular Research Foundation® (CRF®) has announced New York Valves: The Structural Heart Summit will feature 12 Late-Breaking Clinical Trials and Science presentations. New York Valves 2024, the expanded iteration of our renowned annual Transcatheter Valve Therapy (TVT®) conference, will take place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City.

Not for public release

This news release is embargoed until 19-May-2024 5:15 PM EDT Released to reporters: 13-May-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2024 5:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded social-jet-lag-leads-to-weight-gain-and-increased-blood-sugar-in-mice
VIDEO
Released: 16-May-2024 7:05 AM EDT
‘Social Jet Lag’ Leads to Weight Gain and Increased Blood Sugar in Mice
American Physiological Society (APS)

Mice experiencing “social jet lag” developed characteristics similar to people with the same phenomenon, including significant weight gain, higher blood sugar levels and lower cardiovascular fitness.

Released: 15-May-2024 11:05 AM EDT
Improving Life Quality in Chronic Limb-Threatening Ischemia Through Revascularization
Ochsner Health

A recent publication in the American Heart Association Circulation highlights the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia.

Newswise: MedStar Health Patients are First in the Region to Receive FARAPULSE™ Pulsed Field Ablation to Treat Atrial Fibrillation at 
MedStar Washington Hospital Center
Released: 15-May-2024 8:45 AM EDT
MedStar Health Patients are First in the Region to Receive FARAPULSE™ Pulsed Field Ablation to Treat Atrial Fibrillation at MedStar Washington Hospital Center
MedStar Washington Hospital Center

MedStar Washington Hospital Center is the first in the greater Washington and Baltimore regions to use the FARAPULSE™ Pulsed Field Ablation (PFA) System, an innovative cardiac ablation therapy to treat atrial fibrillation (AFib), the most common heart rhythm disorder in adults. Traditional ablation therapies have relied on heat or cold energy to block the abnormal electrical signals responsible for AFib.

Newswise: Atrium Health Wake Forest Baptist and Forsyth County EMS Launch Innovative Program to Improve Cardiac Arrest Outcomes
Released: 14-May-2024 2:05 PM EDT
Atrium Health Wake Forest Baptist and Forsyth County EMS Launch Innovative Program to Improve Cardiac Arrest Outcomes
Atrium Health Wake Forest Baptist

Atrium Health Wake Forest Baptist and Forsyth County EMS have launched a program, believed to be the first in North Carolina, designed to improve outcomes for patients suffering from cardiac arrest.

Newswise: Using AI to repurpose routine CT scans
Released: 14-May-2024 2:05 PM EDT
Using AI to repurpose routine CT scans
National Institute of Biomedical Imaging and Bioengineering

A collaborative NIH-funded team is using AI to mine common chest CT scans to predict mortality. Their research identified a collection of cardiac factors that were predictive of death in a large group of patients, potentially setting the stage for improved cardiac screening.

   
Newswise: 1920_gettyimages-165666036.jpg?10000
Released: 14-May-2024 12:05 PM EDT
Smidt Heart Institute Experts Available to Discuss Heart Rhythm Society Presentations
Cedars-Sinai

Investigators from the Smidt Heart Institute at Cedars-Sinai are presenting more than 40 original research studies at the Heart Rhythm Society annual meeting in Boston, May 16-19.

Newswise: Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Providing Novel Irregular Heart Rhythm Treatment
Released: 14-May-2024 9:05 AM EDT
Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Providing Novel Irregular Heart Rhythm Treatment
Hackensack Meridian Health

Hackensack Meridian Hackensack University Medical Center and Hackensack Meridian Jersey Shore University Medical Center cardiologists have treated their first patients this week with the Medtronic PulseSelect Pulsed Field Ablation (PFA) System.

Not for public release

This news release is embargoed until 13-May-2024 4:00 PM EDT Released to reporters: 7-May-2024 1:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Turning to Artificial Intelligence to Disentangle the Exposome
Released: 13-May-2024 12:15 PM EDT
Turning to Artificial Intelligence to Disentangle the Exposome
Harvard Medical School

Understanding the human exposome — a person’s myriad health exposures over a lifetime — can reveal unknowns about diseases not explained fully by our DNA. Artificial intelligence will be indispensable in efforts to understand the role of biology and environment in disease and health.

Released: 13-May-2024 11:05 AM EDT
Ochsner Medical Center-Baton Rouge earns Acute Stroke Ready Certification from Joint Commission
Ochsner Health

The designation means OMC-Baton Rouge meets The Joint Commission's designation for readiness to treat patients who experience severe stroke.

13-May-2024 9:30 AM EDT
New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy
Lahey Hospital & Medical Center

One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the walls of the left ventricle to become thick and stiff. In about 70 percent of cases, patients with HCM experience obstruction to blood flow, which increases pressures in the heart and can lead to chest pain, shortness of breath and reduced exercise capacity.

Released: 13-May-2024 8:05 AM EDT
Researchers create human aortic aneurysm model to advance disease understanding, treatment testing
Michigan Medicine - University of Michigan

There are currently no medical treatments for thoracic aortic aneurysm. Using human cells in laboratory rats, researchers have developed a functional model of thoracic aortic aneurysm, creating opportunities for more effective understanding of disease development and treatments for the potentially fatal condition, a study suggests.

Newswise: Biomarker found to help identify cells that can repair damaged blood vessels
Released: 8-May-2024 8:00 AM EDT
Biomarker found to help identify cells that can repair damaged blood vessels
Indiana University

Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronary artery disease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.



close
3.46118